Live: Will Alphabet Smash Q2 Earnings Tonight After Berkshire Hathaway’s Big Bet?

Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

616 Articles

Chris Lange | Nov 2, 2018 at 10:23 AM EDT

AbbVie Little Changed Despite Big Bottom-Line Beat

AbbVie released its third quarter financial results before the markets opened on Friday. The pharma giant said that it had…

Paul Ausick | Nov 1, 2018 at 2:08 PM EDT

Encana, Hanesbrands Sink into Thursday’s 52-Week Low Club

Encana, Hanesbrands, Abbvie, and Annaly Capital Management all posted new 52-week lows Thursday.

Chris Lange | Oct 25, 2018 at 9:00 AM EDT

Major Pharma Short Sellers Hike Their Bets

The October 15 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Oct 25, 2018 at 7:10 AM EDT

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

These four top pharmaceutical companies have longstanding franchises with huge sales and revenues, and their dividend-paying stocks look like outstanding choices…

Chris Lange | Oct 10, 2018 at 9:10 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Oct 4, 2018 at 12:10 PM EDT

Rising Interest Rates and All, 13 Blue Chips Outyield 10-Year and 30-Year Treasuries

Here are 13 companies with solid dividends that currently yield more than both the 10-year Treasury note and the 30-year…

Chris Lange | Sep 26, 2018 at 8:50 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Sep 19, 2018 at 1:50 PM EDT

Should AbbVie Be More Concerned About Its California Case for Humira?

AbbVie shares took a dip on Wednesday after it was announced that the pharma giant would be facing a lawsuit…

Chris Lange | Sep 13, 2018 at 9:55 AM EDT

Short Sellers Back Off Major Pharma Stocks

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Aug 27, 2018 at 7:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Aug 22, 2018 at 11:10 AM EDT

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team…

Jon C. Ogg | Aug 15, 2018 at 11:50 AM EDT

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors.…

Chris Lange | Aug 10, 2018 at 9:50 AM EDT

Short Sellers Hike Bets in Major Pharma Stocks

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 27, 2018 at 11:20 AM EDT

Why AbbVie Earnings Were Not Enough for Investors

AbbVie released a better-than-expected quarterly report early on Friday, but shares retreated afterward.

Chris Lange | Jul 25, 2018 at 7:35 AM EDT

Major Pharma Stocks Scare Off Short Sellers

The July 13 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 20 21 22 23 24 … 42

AbbVie : ABBV

All AbbVie Articles

AbbVie Little Changed Despite Big Bottom-Line Beat

Encana, Hanesbrands Sink into Thursday’s 52-Week Low Club

Major Pharma Short Sellers Hike Their Bets

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

Short Sellers Run for Cover From Major Pharma

Rising Interest Rates and All, 13 Blue Chips Outyield 10-Year and 30-Year Treasuries

Short Sellers Grow More Selective on Major Pharma Stocks

Should AbbVie Be More Concerned About Its California Case for Humira?

Short Sellers Back Off Major Pharma Stocks

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

Short Sellers Hike Bets in Major Pharma Stocks

Why AbbVie Earnings Were Not Enough for Investors

Major Pharma Stocks Scare Off Short Sellers

Live: Will Alphabet Smash Q2 Earnings Tonight After Berkshire Hathaway’s Big Bet?

Live: Will Tesla Crush Tonight’s Q2 Earnings After Big Delivery Volume Beat?

Live: Will ServiceNow’s Q2 Earnings Tonight Drive a Rebound After 38% YTD Decline?

Forget QQQ. This Semiconductor Fund Nearly Quintupled Its 2026 Gain

Between 67 and 70, Social Security Pays You a Guaranteed 8% a Year Just to Wait. No Bank on Earth Matches It

The Ultimate Bull Run for NVIDIA, Micron, and SanDisk May Be Closer Than Investors Think

Between 67 and 70, Social Security Pays You a Guaranteed 8% a Year Just to Wait. No Bank on Earth Matches It

She Divorced at 66 and Her Income Never Changed. Her Medicare Bracket Did.

Chasing Yield Is a Trap. These 3 Dividend ETFs Pay You Without the Risk

Forget QQQ. This Semiconductor Fund Nearly Quintupled Its 2026 Gain

AbbVie : ABBV

All AbbVie Articles

AbbVie Little Changed Despite Big Bottom-Line Beat

Encana, Hanesbrands Sink into Thursday’s 52-Week Low Club

Major Pharma Short Sellers Hike Their Bets

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

Short Sellers Run for Cover From Major Pharma

Rising Interest Rates and All, 13 Blue Chips Outyield 10-Year and 30-Year Treasuries

Short Sellers Grow More Selective on Major Pharma Stocks

Should AbbVie Be More Concerned About Its California Case for Humira?

Short Sellers Back Off Major Pharma Stocks

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

Short Sellers Hike Bets in Major Pharma Stocks

Why AbbVie Earnings Were Not Enough for Investors

Major Pharma Stocks Scare Off Short Sellers

Live: Will Alphabet Smash Q2 Earnings Tonight After Berkshire Hathaway’s Big Bet?

Live: Will Tesla Crush Tonight’s Q2 Earnings After Big Delivery Volume Beat?

Live: Will ServiceNow’s Q2 Earnings Tonight Drive a Rebound After 38% YTD Decline?

Forget QQQ. This Semiconductor Fund Nearly Quintupled Its 2026 Gain

Between 67 and 70, Social Security Pays You a Guaranteed 8% a Year Just to Wait. No Bank on Earth Matches It

The Ultimate Bull Run for NVIDIA, Micron, and SanDisk May Be Closer Than Investors Think

Featured Reads

Between 67 and 70, Social Security Pays You a Guaranteed 8% a Year Just to Wait. No Bank on Earth Matches It

She Divorced at 66 and Her Income Never Changed. Her Medicare Bracket Did.